Familial intestinal polyposis and device assisted enteroscopy: where do we stand?

Giuseppe Losurdo,Milena Di Leo,Salvatore Rizzi,Ilaria Lacavalla,Francesca Celiberto,Andrea Iannone,Maria Rendina,Enzo Ierardi,Giuseppe Iabichino,Luca De Luca,Alfredo Di Leo
DOI: https://doi.org/10.1080/17474124.2023.2242240
2023-07-31
Abstract:Hereditary polyposis syndromes are a group of inherited disorders associated with a high risk of developing colorectal cancer. The best known ones are familial adenomatous polyposis (FAP), Peutz-Jeghers (PJS), juvenile polyposis and Cowden syndromes, as well as conditions predisposing to cancer, such as Lynch syndrome. Some of them are characterized by an increased risk of small bowel polyps occurrence. Literature search in PubMed was performed in November 2022 and a narrative review was carried out. Since performing small bowel polypectomy is important in such patients, device assisted enteroscopy (DAE) is the key for this procedure. A screening strategy for small bowel polyps is recommended only for PJS. Guidelines endorse either magnetic resonance imaging (MRI) or videocapsule endoscopy (VCE) every 1–3 years, according to the phenotype of the disease. Enteroscopy should be considered for therapeutic purpose in patients with a positive VCE or MRI. DAE has a central role in the resection of polyps larger than mm or causing symptoms of subocclusion or intussusception. Both single (SBE) and double balloon enteroscopy (DBE) are indicated and able to resect polyps up to 6–10 cm. American guidelines have restricted the indications to small bowel enteroscopy only to FAP patients with grade IV Spiegelman. Only some groups of patients (PJS, FAP with demonstrated small bowel polyp burden) may benefit from DAE.
gastroenterology & hepatology
What problem does this paper attempt to address?